Loading organizations...
Loading organizations...
Gene therapy company developing new medicines for global markets.
Exegenesis Bio has raised $50.0M across 1 funding round.
Exegenesis Bio has raised $50.0M in total across 1 funding round.
Exegenesis Bio has raised $50.0M in total across 1 funding round.
Exegenesis Bio's investors include Hillhouse Capital Group, CPE, Lake Bleu Capital, LYFE Capital, Temasek Holdings.
Exegenesis Bio has raised $50.0M across 1 funding round. Most recently, it raised $50.0M Series B in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 23, 2021 | $50.0M Series B | Hillhouse Capital Group | CPE, Lake Bleu Capital, LYFE Capital, Temasek Holdings |